本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vogenx

31.53
+0.80002.60%
盤後31.530.00000.00%16:04 EDT
成交量:13.60萬
成交額:452.81萬
市值:4.38億
市盈率:-109.88
高:35.50
開:31.04
低:30.80
收:30.73
52周最高:35.50
52周最低:12.95
股本:1,390.56萬
流通股本:625.00萬
量比:0.29
換手率:2.18%
股息:- -
股息率:- -
每股收益(TTM):-0.2870
每股收益(LYR):-0.2652
淨資產收益率:--
總資產收益率:--
市淨率:-313.15
市盈率(LYR):-118.91

資料載入中...

公司資料

公司名字:
Vogenx
交易所:
NASDAQ
成立時間:
2021
員工人數:
5
公司地址:
3901 Barrett Drive,Suite 300,Raleigh,North Carolina,United States
郵編:
27609
電話:
傳真:
- -
簡介:
Vogenx, Inc.於2021年2月5日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,專註於發現和開發新療法,用於治療與人體代謝功能障礙相關的嚴重疾病,包括減肥后低血糖或PBH,以及胃輕癱。

董事

名稱
職位
James Green
Chairman of the Board and Chief Executive Officer and Director and President
Steven Delmar
Chief Financial Officer and Corporate Secretary and Director
William Wilkison
Chief Scientific Officer and Director
Peter Pieraccini
Director
Richard Gorman
Director
Timothy Boris
Director

股東

名稱
職位
James Green
Chairman of the Board and Chief Executive Officer and Director and President
Steven Delmar
Chief Financial Officer and Corporate Secretary and Director
William Wilkison
Chief Scientific Officer and Director